Objective
Cancer continues to be an important public health concern and socio-economic problem. Among the most promising newly established drugs, palliate (Taxi) and docetaxel (Texture) have the broadest ant tumour spectra in the clinic and are used increasingly for the treatment of ovarian cancer and metastasis breast cancer, with promise also for the treatment of lung, skin, and head and neck cancers. However, this beneficial effect still remains hampered by many drawbacks. The major cellular target for palliate and other taxies is the protein tubule, whose polymerisation into microtubules is induced and stabilised, blocking the tumour cells in mitosis and preventing proliferation. Recently, several natural products isolated both from marine sources (soft corals or sponges) and from terrestrial bacteria have been reported to exert potent catatonic activity through a related-related mechanism. Among these, sarcodictyins A and B and eleutherobin (the " eleutheside" family of microtubule- stabilizing agents) are active against paclitaxel-resislant tumour cell lines and therefore hold potential as second generation microtubule-stabilizing anticancer drugs. Given the scarcity of the natural products, a practical total synthesis of the eleuthesides (amenable to large-scale preparation at a reasonable cost), and the synthesis of simplified eleutheside analogues, are still strongly desirable. The central aim of this project is to use the expertise gained within the group in the preparation of tri- substituted eleutheside analogues, and attempt the synthesis of: (a) a number of new eleutheside analogues functionalized at C-7; (b) the fully functionalised analogues, from which the Danishes key-intermediate (an advanced intermediate in the total synthesis of eleutherobin) could be easily obtained. Our plan is to screen these compounds both on biochemical tests, like tubule assembly, and on cellular tumour models.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences public health
- natural sciences biological sciences microbiology virology
- medical and health sciences clinical medicine oncology breast cancer
- medical and health sciences clinical medicine oncology head and neck cancer
- medical and health sciences basic medicine immunology immunotherapy
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-5
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
MILANO
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.